| Analysis | Metabolite Name | Measured Value | Units | Sample type | Gender |
|---|---|---|---|---|---|
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 218 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 14099 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 14141 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 14557 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 14676 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 16059 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 16225 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 16298 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 16374 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 16910 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 17419 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 17477 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 17859 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 18280 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 18411 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 18507 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 18671 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 18789 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 18829 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 18870 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 18977 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 19000 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 19001 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 19236 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 19383 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 19705 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 20392 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 20870 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 21255 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 21585 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 21747 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 21775 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 21791 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 21967 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 22011 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 22124 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 22153 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 22172 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 22202 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 22296 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 22341 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 22842 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 22948 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 23050 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 23083 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 23281 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 23290 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 23324 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 23334 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 23347 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 23423 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 23606 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 23703 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 23908 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 23943 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 23949 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 24007 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 24009 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 24012 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 24130 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 24259 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 24405 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 24444 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 24482 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 24639 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 24727 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 24793 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 24825 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 24870 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 25012 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 25118 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 25157 | Peak area normalized | master pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 25220 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 25238 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 25396 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 25411 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 25467 | Peak area normalized | master pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 25548 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 25682 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 25896 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 26011 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 26133 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 26156 | Peak area normalized | master pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 26238 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 26303 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 26349 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 26356 | Peak area normalized | master pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 26398 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 26407 | Peak area normalized | master pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 26465 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 26498 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 26533 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 26571 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 26579 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 26580 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 26648 | Peak area normalized | master pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 26657 | Peak area normalized | master pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 26660 | Peak area normalized | master pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 26686 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 26699 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 26711 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 26727 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 26746 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 26762 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 26779 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 26801 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 26806 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 26819 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 26831 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 26842 | Peak area normalized | master pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 26856 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 26866 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 26891 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 26992 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 27004 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 27009 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 27019 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 27034 | Peak area normalized | master pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 27055 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 27061 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 27078 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 27101 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 27105 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 27108 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 27126 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 27131 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 27138 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 27138 | Peak area normalized | master pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 27166 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 27194 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 27201 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 27218 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 27257 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 27314 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 27351 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 27403 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 27439 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 27444 | Peak area normalized | master pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 27452 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 27627 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 27629 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 27643 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 27664 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 27720 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 27731 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 27754 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 27797 | Peak area normalized | batch pool | - |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 27845 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 27996 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 28045 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 28060 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 28063 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 28067 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 28081 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 28172 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 28197 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 28721 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 28908 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 28975 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 29032 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 29170 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 29187 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 29220 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 29547 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 29770 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 29792 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 30012 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 30046 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 30239 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 30260 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 30343 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 30370 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 30583 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 30586 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 30831 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 30973 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 31081 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 31136 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 31249 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 31297 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 31484 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 31785 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 31908 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 32126 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 32145 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 32253 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 32600 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 32685 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 33404 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 33843 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 34048 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 34048 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 34392 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 34565 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 34785 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 35085 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 35128 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 35867 | Peak area normalized | Sample | female |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 35969 | Peak area normalized | Sample | male |
| Reversed Phase NEGATIVE (Named metabolites) | gamma-glutamylleucine | 36068 | Peak area normalized | Sample | male |
Return to search page
